ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

Fredrickson, Upton Kill Plan To Convert FCRC To NIH Satellite, Will Continue L-B Contract

February 9, 1979

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985